DJ Novavax Inc. Stock Underperforms Thursday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ slumped 0.25% to $8.04 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.03% to 18,972.42 and the Dow Jones Industrial Average rising 1.06% to 43,870.35.
The stock's fall snapped a four-day winning streak.
Novavax Inc. closed $15.82 below its 52-week high ($23.86), which the company reached on June 6th.
The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ rose 1.56% to $155.50, Pfizer Inc. $(PFE)$ rose 0.76% to $25.13, and Merck & Co. Inc. $(MRK)$ rose 2.48% to $99.86.
Trading volume (3.1 M) remained 3.5 million below its 50-day average volume of 6.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 21, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
November 21, 2024 17:29 ET (22:29 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。